68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study

ObjectiveTo compare the diagnostic accuracy of Ga-68-prostate-specific membrane antigen (PSMA)-HBED-CC PET/computed tomography (CT) imaging for the detection of androgen-dependent recurrent prostate carcinoma (ADPC) in Black South Africans (BSAs) versus White South Africans (WSAs) with increasing serum prostate-specific antigen (PSA) values below or equal to 10ng/ml.Patients and methodsA total of 61 patients with ADPC were prospectively included in the study (mean age: 66.7 years): 38 WSAs and 23 BSAs. Ga-68-PSMA-HBED-CC PET/CT imaging results obtained were related to serum PSA levels and to ethnicity.ResultsA total of 41 (67%) patients had a positive Ga-68-PSMA-HBED-CC scan result. Ga-68-PSMA-HBED-CC PET/CT positivity was significantly higher in patients with PSA values more than 2ng/ml [32/38 (84%) patients] when compared with patients with PSA values less than 0.5ng/ml [6/11 (55%) patients] or PSA values of 0.5-2ng/ml [3/12 (25%) patients] (P=0.0001). Mean PSA values proved not significantly different in patients presenting with extrapelvic involvement when compared with those with intrapelvic involvement or between patients who presented with bone involvement versus those who did not on Ga-68-PSMA-HBED-CC PET/CT) (P0.147). Age, Gleason-scores, median PSA values, the frequency of a positive scan result, the frequency of bone involvement, and extrapelvic involvement proved similar in WSAs and BSAs (P0.417).Conclusion(68)Ga-PSMA-HBED-CC PET/CT imaging identified a recurrence in 67% of the patients under study. Higher PSA levels were associated with Ga-68-PSMA-HBED-CC PET/CT positivity and the detection rate. Imaging results obtained proved similar in BSAs and WSAs, suggesting that the tumor burden and growth rate of ADPC are similar in both races.